{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:23:06Z","timestamp":1707524586496},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,6,1]]},"DOI":"10.7759\/cureus.25576","type":"journal-article","created":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T19:42:36Z","timestamp":1654112556000},"source":"Crossref","is-referenced-by-count":0,"title":["Lubiprostone for the Treatment of Clozapine-Induced Constipation: A Case Series"],"prefix":"10.7759","author":[{"given":"Tyler J","family":"Torrico","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Snehpreet","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manik","family":"Dayal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pooja","family":"Eagala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Weinstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-244X-14-102","article-title":"Clozapine: a review of clinical practice guidelines and prescribing trends","volume":"14","author":"Warnez S","year":"2014","unstructured":"Warnez S, Alessi-Severini S. Clozapine: a review of clinical practice guidelines and prescribing trends. BMC Psychiatry. 2014, 14:102. 10.1186\/1471-244X-14-102","journal-title":"BMC Psychiatry"},{"key":"ref2","unstructured":"FDA strengthens warning that untreated constipation caused by schizophrenia medicine clozapine (Clozaril) can lead to serious bowel problems. (2020). Accessed. 2022: https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-strengthens-warning-untreated-constipation-caused-schizoph...."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17060863","article-title":"Prevalence and predictors of clozapine-associated constipation: a systematic review and meta-analysis","volume":"17","author":"Shirazi A","year":"2016","unstructured":"Shirazi A, Stubbs B, Gomez L, et al.. Prevalence and predictors of clozapine-associated constipation: a systematic review and meta-analysis. Int J Mol Sci. 2016, 17:863. 10.3390\/ijms17060863","journal-title":"Int J Mol Sci"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/s43045-021-00097-6","article-title":"Management of constipation in patients with schizophrenia - a case study and review of literature","volume":"28","author":"Sarangi A","year":"2021","unstructured":"Sarangi A, Armin S, Vargas A, Chu VM, Fain K, Nelson J. Management of constipation in patients with schizophrenia - a case study and review of literature. Middle East Curr Psychiatry. 2021, 28:17. 10.1186\/s43045-021-00097-6","journal-title":"Middle East Curr Psychiatry"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.2022.24","article-title":"Clozapine-induced gastrointestinal hypomotility: presenting features and outcomes, UK pharmacovigilance reports, 1992-2017","volume":"220","author":"Handley SA","year":"2022","unstructured":"Handley SA, Every-Palmer S, Ismail A, Flanagan RJ. Clozapine-induced gastrointestinal hypomotility: presenting features and outcomes, UK pharmacovigilance reports, 1992-2017. Br J Psychiatry. 2022, 220:355-63. 10.1192\/bjp.2022.24","journal-title":"Br J Psychiatry"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1177\/2045125315591917","article-title":"Factors predicting use of laxatives in outpatients stabilized on clozapine","volume":"5","author":"Bailey L","year":"2015","unstructured":"Bailey L, Varma S, Ahmad N, Gee S, Taylor DM. Factors predicting use of laxatives in outpatients stabilized on clozapine. Ther Adv Psychopharmacol. 2015, 5:256-62. 10.1177\/2045125315591917","journal-title":"Ther Adv Psychopharmacol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/acps.12259","article-title":"Lubiprostone for treatment-resistant constipation associated with clozapine use","volume":"130","author":"Meyer JM","year":"2014","unstructured":"Meyer JM, Cummings MA. Lubiprostone for treatment-resistant constipation associated with clozapine use. Acta Psychiatr Scand. 2014, 130:71-2. 10.1111\/acps.12259","journal-title":"Acta Psychiatr Scand"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/9649334","article-title":"Managing recurrent clozapine-induced constipation in a patient with resistant schizophrenia","volume":"2021","author":"Tomulescu S","year":"2021","unstructured":"Tomulescu S, Uittenhove K, Boukakiou R. Managing recurrent clozapine-induced constipation in a patient with resistant schizophrenia. Case Rep Psychiatry. 2021, 2021:9649334. 10.1155\/2021\/9649334","journal-title":"Case Rep Psychiatry"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0000000000000354","article-title":"Prevalence and predictors of laxatives use in clozapine-related constipation: an observational study","volume":"36","author":"Nakamura M","year":"2021","unstructured":"Nakamura M, Nagamine T. Prevalence and predictors of laxatives use in clozapine-related constipation: an observational study. Int Clin Psychopharmacol. 2021, 36:162-7. 10.1097\/YIC.0000000000000354","journal-title":"Int Clin Psychopharmacol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.4103\/IJPSYM.IJPSYM_467_18","article-title":"Clozapine-related constipation: a retrospective study","volume":"41","author":"Grover S","year":"2019","unstructured":"Grover S, Sahoo S, Hazari N. Clozapine-related constipation: a retrospective study. Indian J Psychol Med. 2019, 41:485-7. 10.4103\/IJPSYM.IJPSYM_467_18","journal-title":"Indian J Psychol Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011128.pub2\u00a0\u00a0","article-title":"Pharmacological treatment for antipsychotic-related constipation","author":"Every-Palmer S","year":"2017","unstructured":"Every-Palmer S, Newton-Howes G, Clarke MJ. Pharmacological treatment for antipsychotic-related constipation. Cochrane Database Syst Rev. 2017, CD011128. 10.1002\/14651858.CD011128.pub2\u00a0\u00a0","journal-title":"Cochrane Database Syst Rev"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2003.07465.x","article-title":"Risk factors for chronic constipation based on a general practice sample","volume":"98","author":"Talley NJ","year":"2003","unstructured":"Talley NJ, Jones M, Nuyts G, Dubois D. Risk factors for chronic constipation based on a general practice sample. Am J Gastroenterol. 2003, 98:1107-11. 10.1111\/j.1572-0241.2003.07465.x","journal-title":"Am J Gastroenterol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0705762","article-title":"Role of serotonin in the pathophysiology of the irritable bowel syndrome","volume":"141","author":"Crowell MD","year":"2004","unstructured":"Crowell MD. Role of serotonin in the pathophysiology of the irritable bowel syndrome. Br J Pharmacol. 2004, 141:1285-93. 10.1038\/sj.bjp.0705762","journal-title":"Br J Pharmacol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.2147\/cia.s2938","article-title":"Lubiprostone: a novel treatment for chronic constipation","volume":"3","author":"Lacy BE","year":"2008","unstructured":"Lacy BE, Levy LC. Lubiprostone: a novel treatment for chronic constipation. Clin Interv Aging. 2008, 3:357-64. 10.2147\/cia.s2938","journal-title":"Clin Interv Aging"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/99012-lubiprostone-for-the-treatment-of-clozapine-induced-constipation-a-case-series","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:36:21Z","timestamp":1707507381000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/99012-lubiprostone-for-the-treatment-of-clozapine-induced-constipation-a-case-series"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,1]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.25576","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6,1]]}}}